These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19233645)

  • 1. New prostaglandin derivative for glaucoma treatment.
    Perrino E; Uliva C; Lanzi C; Soldato PD; Masini E; Sparatore A
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1639-42. PubMed ID: 19233645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.
    Feng Z; Hellberg MR; Sharif NA; McLaughlin MA; Williams GW; Scott D; Wallace T
    Bioorg Med Chem; 2009 Jan; 17(2):576-84. PubMed ID: 19101156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins as ocular hypotensive agents; development of an analogue for glaucoma treatment.
    Stjernschantz J
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():63-8. PubMed ID: 7732906
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.
    Stjernschantz J
    Exp Eye Res; 2004 Apr; 78(4):759-66. PubMed ID: 15037110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive effect of profilin on rabbit intraocular pressure.
    Morales M; Gómez-Cabrero A; Peral A; Gasull X; Pintor J
    Eur J Pharmacol; 2007 Jul; 567(1-2):145-8. PubMed ID: 17499235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes.
    Pirie CG; Maranda LS; Pizzirani S
    Vet Ophthalmol; 2011 Mar; 14(2):71-9. PubMed ID: 21366821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandins - - clinical aspects in ophthalmology].
    Malcea C; Nenciu A
    Oftalmologia; 2006; 50(3):22-8. PubMed ID: 17144502
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potential of new hydrogen sulfide-releasing hybrids.
    Sparatore A; Santus G; Giustarini D; Rossi R; Del Soldato P
    Expert Rev Clin Pharmacol; 2011 Jan; 4(1):109-21. PubMed ID: 22115352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans.
    Camras CB
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():519-25. PubMed ID: 7732900
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin analogues: a new classification of ocular hypotensive agents used in the treatment of glaucoma.
    Gallucci GM
    Nurse Pract; 1996 Nov; 21(11):144-6. PubMed ID: 8933541
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments for ocular hypertension.
    Mediero A; Alarma-Estrany P; Pintor J
    Auton Neurosci; 2009 May; 147(1-2):14-9. PubMed ID: 19176290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid provides shortcut to drugs.
    Sanderson K
    Nature; 2012 Aug; 488(7411):266. PubMed ID: 22895313
    [No Abstract]   [Full Text] [Related]  

  • 15. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin analogs for hair growth: great expectations.
    Wolf R; Matz H; Zalish M; Pollack A; Orion E
    Dermatol Online J; 2003 Aug; 9(3):7. PubMed ID: 12952754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
    Konstas AG; Pikilidou MI; Tsironi S; Mikropoulos D; Kozobolis VP; Sarafidis PA; Lasaridis AN; Nelson LA; Stewart WC
    Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
    Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
    Am J Ophthalmol; 2009 Aug; 148(2):221-6. PubMed ID: 19427617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chroman-3-amides as potent Rho kinase inhibitors.
    Chen YT; Bannister TD; Weiser A; Griffin E; Lin L; Ruiz C; Cameron MD; Schürer S; Duckett D; Schröter T; LoGrasso P; Feng Y
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6406-9. PubMed ID: 18990570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins in ocular pathophysiology with special reference to diabetic retinopathy and glaucoma.
    Waitzman MB; Colley AM
    Metab Pediatr Syst Ophthalmol; 1983; 7(1):7-23. PubMed ID: 6353134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.